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Summary 
Tbc high rate of stone rccurrenCt' reprcselit!'o \ drawback of non-o,;~'rt~.kal the-rap~' of cholt::r.~crol ~ütl:;tGnc di~­
east:. Although lllosi sludics r~port i:lat long':'_Tm bile acid treatment dl;~S not hav(;! pTOte.:tive effe.::ts. preiimi-
nilry results suggesl that low-dosL ursodeoxycholic <leid decreases the rate l1f gallstonc recurrem'e in ., 'iUbgrollP 
of youngcr palients. To ctarify the underlying rnechanism we invesligilted whether low-dose ur:.odeoxycholic 
acid trea1ment intluenrelO bilian' ~hokslcrol satur"tion and/or '1udcation time oi chnlestf'rol Tcn p;.nients with 
cholestcrol gallstones und functioning gallhladdt!r rcceived ;~n mg ur~odeo1{ycho1ic acid/day at bedtime 6- 10 
days prior tc chokcystecttln~y. Eh!\'en patienb ,,',th cholcs~crol gall!ottones without treatment served as controls. 
ChuleSle:-.... 1 Cf:' ::1als wen: pr~l>ent in the gallbludder hilI': of 7 Out (lf the 10 patients rCl:dving ursodeoxycholic iu.:id 
und in a1l con!fui biles. ür.~tldcoxy~hclic acid lrcatmo;:;ot significar..!y (P < 0.02) uecreased the cholcst-!ml satu-
raf_oll index (mean ± S.F. : n.44 "t o.!:S V~. 1.0,_1 :t 11. iH) ,md ted ro an approximately 5-fold prolonga!ion (P < 
0.0(5) ur in!:! cholestcrol nudcation time (mean ± S.E.: 12.0 ± 2.4 vs. 2.3 ± 0.7 days). We coocJude that iow-
dose ursvrll:l)xycholic acid might he effecti\'e in the pre\'cntion of po!.t-dissolution gallstone rCLUrrencc by botl1 
:Ie·creasing dHllcst~iOl saturatiun anu prclongmg cholestuul nuclc;.ltiun time. 
IntroducUon 
Several studies have shoV>'1I that supersatur:. "'11 Clf 
hile \ltith cholcsiewl ant.! a rapid formation of choles-
terol t;lvstah playa key roJe in lhl: pathogcnesis of 
\:holt:)tcJ'): •.. 'lllston~s [I 8]. 
Dissolution of lhe sloncs within the gallh!l!ddcr call 
he achi~vcd by oral administration of chenodeoxy~ 
dlClic J.dd (CDCA) 19-11}, llr50d~oxycholic at:ic 
(UDe,\) VI a combination ofbotl1 [12-15J. More f.:-
cent swdics have shown that exrrarorporeal ~hOCK­
wave lithotripsy cOlllbined with bilc acid therapy für 
fragmt;nt dissolution is a safe and effedive treatment 
in 'Ideeted patiems with radiDIucent gillistones 
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[l6.171. Hvwever~ ~up~rs .. ~turation of bilc and a re-
ducen nllr1eation time· of cho1e!;tero! p;,:::-:oist in most 
patieOl:o. üfler stOI'le: dissolution and contribute to 
stone r":';;ÜI.~·no:.-~ ,,':hic:r. hHS h~en ob:;erved nt n rute of 
about 1097 pc r year uuring the first years (18-201 
Oral administration of low-dose CDCA has been 
ShOWii j)Dt tc b~ cffe-;!ivc in the preVe!"!ticii of stone 
reeurrence after suecessful litholyti,' therapy 121j. 
However, preliminary r.;~üh:.; suggt:'M that 100·v-dose 
UllCA dccrc(lscs the rate of gallstone rccurrence in 
a subgmup of younger patients 122]. 
To darify (he: undc,lying mechanism we investi-
gaied whether jowadose UDCA treatment influences 
baiary cholestcrol salunHion and/or nucleation time 
in paticnl-s with cholcsterol gaUstones . 
Materials und Mcthods 
Patient.< .nd wlleetion oi bile 
Tweniy Gnt paticnts who underwcnt clcctive 
cho]ecyslectomy bC~~'11SC of symptomatic gall!-.tones 
were selccted for the stuay. 0!lt uf the cntire r.: &p~la· 
tion undergoin?, cbolccystcctomy the patients 01 the 
stuJy were s.lected .CCOI di,'g to tne followmg crite· 
ria: functioning gallbladde, doeumented by visualiza· 
ti on of the gailbladdcr by oral eholccystog,aphy 0' 
scilll.igi'aphy wiihin 6 weeks prior to sUn.!cry and "hQ-
lestero! contet1 ( of thc rcmoved stOiiC:i ubove 60%. 
T~n patients. '/ females .nd 1 male. with a mean age 
of 50.~ years (range: 23-68 ye.rs) .lId a mean body· 
w~jght of 66.0 kg (range. 47-90 kg) were trcated 
6-10 days pri!)!' te cholecY'"te~tomy with 250 mg 
UDCA per day given at bedtime. Eleven paticnts. 7 
female. and 4 male<. with :t me an .ge of 46.2 yenrs 
(r.t'~.:: ·q-79 years) and a moan ~odyweight of 68.0 
kg (range: 48-89 kgl servecl a' eontmL: Gallbladder 
bile was aspira1ed duriog surgery by puncturc uf the 
gaUhladder after ligation of tht: ~:>,s1ic um::t nsing a 
sterile needh.: and syringe. Particular care W3" taken 
lo colle<,'1 g~a:"h\dJel bile complctcly. in order to 
<woid cffccts 0" stratifkc.ttion 123}. The stones were 
.. mlwe<! with Ihe gallbladder. washed. and analy<e<! 
for cholesterol content. Thc mean cholcsterol con-
tent of the stonl!s, (71.3% VS. 76.8%) wa~ not signifi-
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canti" diffl:fefil hetw~en the groups of patients. 
Biliary m;crMcoPY 
After collection. bik samplö ","re mixed thor-
oughly and one drop was immf'diately cxamincd by 
polarizcd light mkroscopy for cholesterol crystals. 
Because small numbers ..Jf crystais might be over-
100ked by the miciOscopic cxaminatioi1 of un~pun 
NIe, thc sediment of the bile sampies was fe-exam-
ined for cholesterol crystals after uhracentrifugation 
(100000 x g for 2 h). 
For the determination of cholestcrol '"!ucleation 
time 4 ml of gdl!bladder bile were ecntrifuged for 2 h 
al 100 tlOO x g in • Beekman L 50 ultracentrifuge 
(Beckman In<'rnm.n". Fullerton. CA. U.S.A.) to 
obtain ~rysta!-free bile as describcd by Ho].&n et al. 
121. The top j 111; was dis<aldcd "nd the next 2 ml (in· 
terphast;;) were rcmovcd by a"ipiration. An aliquot cf 
the interphase was immediately e,.amined micro· 
scopically to confirm the absence of erystals; the rest 
was placed in steiHe tubes~ ßushed with nitrogen. 
scalod and incubated .1 37 oe. Twice daily for up to 3 
weeks the interphase was illvcstigated for the apo 
pearanee of cholesterol eryst.ls. The interval be· 
Iween time zeiO and the first detee' ion Of a eholester· 
01 cryr.tal in the sam pIe was taken as thc nudeation 
time. 
Allalysis of Me 
For analysis of bilc i'~ids. duplkate aliquots were 
storcd at -40 oe prior to 1etermination. Cholesteeel 
was determincd colorimeh :cally after extraction with 
petroleum ether 124]. Phospholipids were measured 
using the colorimetric assay of Fi~ke and SubbaRow 
125) and total bilc salt. were determind by a modi· 
fied 3a·hydro"yst~roid dehydfl'genasc melhod (261. 
The saturation index of eaeh s.mple was ealculated 
by dividing thc ..:holcsteroll;:ou,cl1tration by thl~ max-
imum chll1l'stl'rol solubiu~_' according to Carey [27~ 
Individual bile acids were determined by capillary 
gas liquid chromatography. A 20-m polyethylene gl~" 
col 20000 ""Iumn (i.d. 0.32 mm) and hydrogen as 
carrier gas were ll.ed [28]. The gas ehromalograph 
was a Carlo Erba 4160 model with an on-(.:o]umn ina 
jection system and flame ionization detection (delec-
UDC'A H;'O:'Q!'1{;S CHOLESTEROL l'Il!CLEAT10K IN BI!..E 
~l" i .. mp~i·u~~rl,; ~5D -·C). A l~rnp~'~li.t,,,, P'u.:;. •. .IIh 
(60-240 'Co 30 Timiol) allowed an oprimal il1jeCIIG 
tecnni'lue. Quantitatio!! was performed using an in· 
ternal standard (hYCldccx)cholic acid) and a multi· 
point calibration obtail1td with ~ Specrra PhY$ics sr· 
4100 int~grator plotter. Sampie preparation Iflcluded 
«nzymatic hydrolysis of glycine and taurine conju· 
ptes an<! ellTraCIun wirh diethyl ether after acidific3· 
cation to pH I wirh eoneentrated hydroehloTic acid. 
T"e f1ce ocids. wert:; methylated using an acidified 
(pI-! I) mixture of methallol and 2.2·dimelhoxypro· 
pane tU vi\') and trimethyl silylared with a mixture 
01 hexamethyldisilasane und trimethylchlorosilalle in 
pyridine (2: 1:3 viv) at morn ternpt!rat~re für 30 min. 
SJati5'tica! analysis 
The results are expr.:"elf a< mean ± standard er· 
rof oi the mean (S.E.). Th .. Student I-test \Vas ap· 
plied 10 asse.:;s thc stlltistical si!!nific~nce of diffe!· 
enCf. be!we~n m""n5. A P value of < U.U5 was con· 
siut!red statistically signilieHm. 
Re""U, 
Biliary microscopy and cholesrerol nuclca/ian time 
Cholesterol crystals wcrc present in the n~ti\le hil.., 
TAB/.E I 
in7 out of I'.) patit'l'Its umter UDCA therapy anct in uil 
t>iles of th!; 11 control palie,~t~. lhe cholp<teroJ I1U-
cleation time was significanl!y (,D « 0.0(5) km);er 
(12.04 ± :2.40 vs. 2.35 ± 0.72 d~y~) in p~tiems recdv· 
illg low-,cosc UDCA thUil in untreated conlrols. The 
!ingl<:: velues are given in Tables 1 and 2. 
Büiary lipid compo.~itlOn 
Tbe single va!ues of both groups i(li total bile 
~cids. pho"pholipids. chole,.terol, total lipids alld the 
chokslcrol ,::\tur.liDn index (eSl) in Ihe gallbladder 
bile~. are displayed in Table3 1 and 2. Stati,!kal a;;,.:y. 
sis of the d3ta revealed signilicamly (P < lI.OS) 
higher values of total bile acids (94.88 ± 9.2; ~,. 
70.54 :!: 4.7'3 mmolll) and signiflcantly (p <:: 0.02) 
lower eSl (0.94 ± 0.1i5 vs. l..H .+. 018) in s1.lbjects 
treated with UDCA (;)mpared tll eootmls. N(l sig· 
l1ifi~a!1t <lifterence between Ihe groups co"l<;) t>e ob· 
tained for bihary phospholipids, cholesterol or total 
lipids. 
bidilr'idual bile acids 
Thc m"l~r perc.ntages 01 IIIJi"iduai olle acids in 
gallbladder bile of botn groups of patit:nts are cam· 
pared ill Fig, 1. The relative ümount of CDCA was 
significantly (P < O.OO!) lower in patiellts re(eiving 
UDCA while cholic. deoxycholic and lithocholic acid 
('}MP0"ITION AND CHOLESTEROL ~WctEA'i'ON TIME IJF GAllBl"DDER BILES OF Ul PATIENiS UNDER 
·,'ftEATMENTWITH LOW·DOSE UDCA ,250 rtgfday)~-IO DA \'S PRfOR TO CHOlECiSTE.CTOMY 
_._---~ --~------ -- -- -_._~--
Patient Age(yr» Nucl.::a1ion Bjlcacids Ph"'pholipids Cbolc .. crol Totallir,d:; eS) 
time (day,) (mmul/I) rmmoll!) (mmolll) (r/dl) 
--~----
- - ----~--- ------
E.K. 6lJ 4.3 43.0 16.3 2.9 3.5 tl.69 
A.S.' 57 21.0 51.i !3.U 4.~ 3.8 1.27 
K.A. &1 3,9 IJ.i.9 39.0 13.1 9.2 1.06 
M.A. 55 3.9 }g!.1 68.5 14.9 14.8 0.68 
B.R. ~> S.O 81.5 :14.0 7.7 7.1 1).81 
R.E. 35 16.6 RS.4 'R.O 11.3 7.7 1.07 
K.S.' 63 20.0 105.8 40.3 9.7 8.7 0.82 
L.u. 51) 3.8 83.5 32.5 7.0 6.9 0.78 
1.P. 6K 21.0 ~5." 44.~ !'~ . i R5 1.14 
U.S· 16 21.0 t48.0 69.0 t9.2 t3.4 0.95 
Moan ± S.E. '0.8 ±4.4 12.0:t2.4 94.9 ± 9.3 39.5 ± S.g 1O."± 1.4 8.1 j:lJ." 0.9~ ± (1.1)5 
._._~--, -_._-
• No <hol.sl.rol cty>laJ, in hiic. 
CSI = c-hoJestcrolsaturaliQn inde'1r>, 
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TABLF 2 
COMPOSITION I\ND CHOLESTEROL NUCLEATION TIME OF GALLBLADIJER BIL-ES OF 1 I PATIENTS WliH (liO· 
U:.STERJ)/ r.AU.:;TC:-~::S '.l:;T!;(;:"'T'. rfCA i~.~C~~ir~!C~ iG Cl rcu:::C':~n::cn );..;-.... 
----------------~---------
Patient Agc Iyrs) Nudcati'Jn Bilc;l{"id" Phospholipids ~·~!ole:.tcrol TotalliplJ" esl 
l'·,.. .. f(i vs) (mmol/l) {mmol/l) (mm.,I!!) Igldl) 
---
~--_. 
K.M. }n I.H MU 27.5 10.0 5.9 131 
U.G. 19 1.8 X5.1 25.5 In.o 6.5 1.2R 
11.3. 04 0.'" 46.S 21'\.0 7.0 n I 17 
i F 61 1.8 756 28.0 24.3 6.8 2.fH 
N.L. Sx 3.9 56.1i .;7.5 137 62 1.57 
FoN. ~h 8.9 66.5 2J.5 19 I 5.\lO 2,44 
I.~~. 53 2.7 7-l g 20.0 5.0 5.5 O.R5 
A.A 2x 11.'" ~7 '1 33.0 H.4 7.5 IU~9 
T.H. 79 U.fJ 52.2 2R 0 7.5 5.0 1.15 
KR. .15 117 fo-i 2 42.0 J2.0 6.9 1.32 
B.W 29 I.tJ 99.2 67.0 17.4 to"i Li4 
Mcan ± S.E. .Ud ± 5.5 2.3 ± 11.7 70.5 ± 4.8 32.8 ± 3.8 122 ± 1.8 6.5 ± U.5 1.·1-3±1I.18 
~._ .. ~----- .-
eSI .." cholestcrol satunllion index. 
w:::re not significantly different. A:i cxp..:ctcd. the 
perccntage of UDCA in bilc was much higher (lK5 
± 3.2 vs. 2.7 ± U.9%) undcr !hc administration of 
lJDCA. 
COl're[(l(iun uf nucleation time 10 eSI, hiliary lipids 
andage 
No cllrrelations were found bclween the cholcstcr-
01 nucieation lime and the CSI (Fig. 2). Ihe totullip-
~ 60 
Fig. ~. r:..~l:!ti\lc "rnuullt~ofhldi""ldmli bHc acid~ (mcan ± S.E.) 
in gallhladder bllc uf p;:.t;ent~ ,,\'ith -:-holcs.t1!lol gallstoncs: open 
ban. controls: hatchcd ba~s, ur,dcr trcal';.C'nt with 250 mg,' 
day UDCr'\ 6-lOday~; prior 10 choICtvtc~·tuny . .... p < 0.001. 
DCA, dcoxychulk acid; CA ,holie acid: LCA, lithocholic 
aCid. 
ids. total hile acids. phospholipids. rhobI""') and 
age ;, patients receiving UDCA und ",mtrul sub-
jecls. 
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ChDlu'i."li S.t ... i.lil1n 11'16 ... (CSU 
Fig. 2. Correlation or CSl und cholesterol nudeation time in 
gallbladder bile of patient, with cholcst.:rol gallstones: (0) 
control patient!>; (e) puticnb undcr treatment with 25U mg/day 
UDCA i\-lO da}'!'. prior to rholccyslcclomy. 
UDCA PROLONGS CHOLESTEROL NL'CLEATION IN BlLE 
ment wtth a low UDe A dose (250 mg/day givco at 
bcdtime) in patienls \':ho wen: refcrrec tn tht; ~urgi­
cal ut!partmem for dective cholecysteclllmy bccausc 
of symptomatic galistones. Drug compliancc was 
doc:umo.:nted by mC<l:-.ur~nlcnt~ ot t::1c\-~lled UVCA 
concentrations in gallbladdc! bile in an trcated pa-
tients. In patients uilder UDCA treatment the per-
ct:ntage of UDCA in bill: was higher (menn: 18.5 VS. 
2.7%) Iha" in control bites. 
These findings are similar to thc rcsults of Stiehl el 
al. [29), who reported a mc an rclath·e amoum of 
28% of UDCA in cholecystokinin-stimulatod duo",,-
nal bilc 01 patient' recciving 250 mg UDCA/day. Thc 
highe. biliary percelltage 01 UDe A in their 'Il.dy 
might be cau,ed hy Ihe much Ion ger treatment period 
013 months as compared to 6-10 days in our inve,ti-
gi.1tion. The pcriod of treatment with Ut)CA may 
have be'fl too short to achieve a steady state al the 
time Gf bi!e sumpling. The me an proporiions (lf cholic 
(32 vs. 25%). chen(ldeoxychoii~ (28 '15. 31'1r). 
deoxycholic (i9 VS. 16%) 11'1d !:t:,ul'holic (1.5 vs. 
1.8%) <.t.cid were similar in both sll·dies. 
Contpared to controls. UDCA-tredtt::d patients rc-
vealed a significantiy high er mcan concentr~:!ion of 
total bllc acid~ (Y4.>j \'S. 70.S mmol/I) and a signifi· 
cantly lower mean eSI (0.94 V>. 1.43). In 6 patient, 
rcceiving UDCA <l CSI below J was clliculated~ thf' 
remaining 4 were slightly supersaturateJ. Cholcster-
01 monohydiatc crystalo;; wcrc dctected in 7 of th~ 10 
patients. Tht:fe was no dcar relation between the 
pres~nce of crystals and ,he eSI. 'n nne hile wlth the 
highest degree of ~dturation (1.27) no t:hokstcrol 
crystals werc found and two biles wi,h th<" l<1west eSI 
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